Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-28 Sale | 2024-02-29 6:50 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 140 | $88.46 | $12,384 | 71,225 (Direct) | View |
| 2022-11-09 Sale | 2022-11-10 4:30 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,696 | $75.64 | $128,283 | 8,857 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-28 Exercise | 2024-02-29 6:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 325 | $58.49 | 71,225 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 6:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 799 | $55.75 | 71,225 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 6:50 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,264 | $0 | 71,225 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:50 pm | N/A 2034-02-27 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 36,480 | $0 | 71,225 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 6:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 140 | $57.22 | 71,225 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 8:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,479 | $74.65 | 21,423 (Direct) | View |
| 2023-12-05 Tax Withholding | 2023-12-06 3:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,269 | $59.61 | 22,902 (Direct) | View |
| 2023-10-01 Tax Withholding | 2023-10-03 4:36 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 346 | $59.92 | 24,171 (Direct) | View |
| 2023-06-30 Other | 2023-07-10 6:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 375 | $56.78 | 24,892 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 8:54 pm | N/A 2033-02-23 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 22,465 | $0 | 40,561 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 7:20 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 849 | $72.98 | 18,096 (Direct) | View |
| 2022-12-30 Other | 2023-01-04 5:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 275 | $56.78 | 19,220 (Direct) | View |
| 2022-12-22 Option Award | 2022-12-27 6:26 pm | N/A 2032-12-22 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 6,620 | $0 | 6,620 (Direct) | View |
| 2022-12-13 Option Award | 2022-12-15 6:13 pm | N/A 2032-12-13 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 31,000 | $0 | 38,670 (Direct) | View |
| 2022-11-30 Tax Withholding | 2022-12-01 9:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,187 | $72.9 | 7,670 (Direct) | View |
Ownership | 2022-11-07 8:26 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 0 | $0 | 62,802 (Direct) | View |